MET‑RON dual inhibitor, BMS‑777607, suppresses cholangiocarcinoma cell growth, and MET‑RON upregulation indicates worse prognosis for intra‑hepatic cholangiocarcinoma patientsChi‐Tung Cheng, Chun‐Nan Yeh|Oncology Reports|2018Cited by 7